Valneva Anticipates EU Approval for Groundbreaking Chikungunya Vaccine
Jun 1, 2024
Valneva Equities
Valneva Postpones Debt Reimbursements, Strengthening Financial Flexibility
Mar 18, 2024
Valneva SE Initiates Phase 2 Pediatric Trial for Chikungunya Vaccine
Jan 10, 2024